Business Wire

GE HealthCare unveils next-generation SIGNA MRI technology, aiming to boost efficiency, enhance patient experience, and advance sustainability

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA™ MRI technology ...
Hosted on MSN

GE HealthCare wins FDA clearances for next-gen SIGNA MRI portfolio

GE HealthCare Technologies Inc. GEHC recently announced FDA 510(k) clearance for three new magnetic resonance (MR) innovations — SIGNA Sprint with Freelium, a 1.5T sealed magnet MRI system; SIGNA Bolt ...
Seeking Alpha

GE HealthCare achieves MRI portfolio milestone with FDA clearances for next-generation SIGNA MRI technology designed to enhance precision imaging and clinical efficiency

SIGNA Sprint with Freelium, a new 1.5T sealed magnet MRI system, combines a sustainable design with uncompromised image quality, and operational autonomy to expand access to advanced MR, even in ...
Hosted on MSN

GE HealthCare bolsters MRI provision with icometrix acquisition

GE HealthCare has entered an agreement to acquire AI-based brain imaging company icometrix to expand its magnetic resonance (MR) imaging capabilities for neurological disorders. The imaging giant ...
Nasdaq

GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions

The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...